Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma

被引：0
|
作者：
Leonetti, C. [1 ]
Porru, M. [1 ]
Artuso, S. [1 ]
Zappavigna, S. [2 ]
Luce, A. [2 ]
Salzano, G. [3 ]
Lusa, S. [3 ]
De Rosa, G. [3 ]
Caraglia, M. [2 ]
机构：
[1] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy
[2] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy
[3] Univ Naples Federico II, Dept Chem & Pharmaceut Chem Toxicol, Naples, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3367
引用
收藏
页码：S794 / S795
页数：2
相关论文
共 50 条
  • [1] Conjugation with polyamines enhances the antitumor activity of naphthoquinones against human glioblastoma cells
    Romao, Luciana
    do Canto, Vanessa P.
    Netz, Paulo A.
    Moura-Neto, Vivaldo
    Pinto, Angelo C.
    Follmer, Cristian
    ANTI-CANCER DRUGS, 2018, 29 (06) : 520 - 529
  • [2] Zoledronic acid encapsulated into liposomes and nanoparticles: Enhanced antitumor activity in 3D-prostate carcinoma spheroids
    Ohlmann, Carsten
    Schmidt, Johannes
    Kamradt, Joern
    Stoeckle, Michael
    Salzano, Giuseppina
    Junker, Kerstin
    Caraglia, Michele
    De Rosa, Giuseppe
    Unteregger, Gerhard
    CANCER RESEARCH, 2012, 72
  • [3] Zoledronic acid and paclitaxel have synergistic antitumor activity and induce apoptotic tumor cell death at clinically relevant concentrations
    Neville-Webbe, H
    Coleman, RE
    Holen, I
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S132 - S132
  • [4] Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
    Kwak, Tae Won
    Kim, Do Hyung
    Jeong, Young-Il
    Kang, Dae Hwan
    JOURNAL OF NANOBIOTECHNOLOGY, 2015, 13
  • [5] Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
    Tae Won Kwak
    Do Hyung Kim
    Young-Il Jeong
    Dae Hwan Kang
    Journal of Nanobiotechnology, 13
  • [6] Corticorelin Acetate, a Synthetic Corticotropin-releasing Factor with Preclinical Antitumor Activity, alone and with Bevacizumab, against Human Brain Tumor Models
    Gamez, Idoia
    Ryan, Robert P.
    Keir, Stephen T.
    ANTICANCER RESEARCH, 2010, 30 (12) : 5037 - 5042
  • [7] Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models
    Gamez, Idoia
    Ryan, Robert P.
    Reid, Lakesha D.
    Routt, Sheri M.
    Hollister, Beth A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1415 - 1422
  • [8] Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models
    Idoia Gamez
    Robert P. Ryan
    Lakesha D. Reid
    Sheri M. Routt
    Beth A. Hollister
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1415 - 1422
  • [9] ZOLEDRONIC ACID (ZOL) ENCAPSULATED INTO LIPOSOMES AND NANOPARTICLES: ENHANCED ANTITUMOR ACTIVITY IN 3D-PROSTATE CARCINOMA SPHEROIDS
    Schmidt, Johannes
    De Rosa, Giuseppe
    Kamradt, Joern
    Junker, Kerstin
    Stoeckle, Michael
    Caraglia, Michele
    Unteregger, Gerhard
    JOURNAL OF UROLOGY, 2013, 189 (04): : E539 - E540
  • [10] 15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models
    Hilliard, Tyvette S.
    Miklossy, Gabriella
    Chock, Christopher
    Yue, Peibin
    Williams, Philip
    Turkson, James
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 601 - 613
12345